PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 19 days 7 hours 44 minutes
Manesh R. Patel, MD - Untangling the Inter-Relationship Between AF and Coronary Artery Disease
Untangling the Inter-Relationship Between AF and Coronary Artery Disease
Nicola A. Hanania, MD, MS - Expert Perspectives in COPD: A Practical Assessment of the Evidence for Combination Bronchodilator Therapy
Go online to www.peerviewpress.com/h/r347 to view the entire programme with slides.
Paul W. Noble, MD - New Developments in Idiopathic Pulmonary Fibrosis: Updates From the 2014 American Thoracic Society and Implications for Clinical Practice
Go online to www.peerviewpress.com/h/s208 to view the entire programme with slides.
Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Go online to www.peerview.com/VEV860 to view the entire programme with slides.
Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Go online to www.peerview.com/CVU860 to view the entire programme with slides.
Amir T. Fathi, MD - The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Go online to www.peerview.com/UMC860 to view the entire programme with slides.
Roy H. Decker, MD, PhD - The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
Go online to www.peerview.com/JXJ860 to view the entire programme with slides.
Lynette M. Sholl, MD - Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Go online to www.peerview.com/TPF860 to view the entire programme with slides.